Abstract PR240: Evaluation of the Efficacy of An Innovative Oral Formulation of Midazolam for Moderate Sedation in Pediatric Patients. (September 2016) - Guittet, C.; Manso, M.; Casagrande, L.; Raffour, C.; Dekens, J.; Jezraoui, P.; Legrand, A.; Granier, L.; Dupont, H.